1. Matrim Cauthon Matrim Cauthon United States says:

    Thank you for the very good news. I am very much concerned that we have made an enormous mistake from the beginning. Comparing the two methods, it is strange to see that ECMO has become the standard of care for people who need more than a ventilator, when the cost of HBO per patient could be as low as 1% of the cost of ECMO, with even higher oxygen concentration in the blood; no trauma; no chemical anticoagulants; very low risk; probable efficacy against long Covid; and, easily usable at any stage of the disease. It would be good to point out if the reason for stopping this trial was because it would be unethical to withhold the good treatment from the control group. And if the only reason why the 3:1 improvement in this trial was not "statistically significant" was because the trial was too small to enable good reliance on the standard statistical methods.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.